Joseph Cozzitorto
Overview
Explore the profile of Joseph Cozzitorto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
421
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jain A, Agostini L, McCarthy G, Chand S, Ramirez A, Nevler A, et al.
Cancer Res
. 2019 Jul;
79(17):4491-4502.
PMID: 31273064
Patients with metastatic pancreatic ductal adenocarcinoma (PDAC) have an average survival of less than 1 year, underscoring the importance of evaluating novel targets with matched targeted agents. We recently identified...
2.
Parasido E, Avetian G, Naeem A, Graham G, Pishvaian M, Glasgow E, et al.
Mol Cancer Res
. 2019 Jun;
17(9):1815-1827.
PMID: 31164413
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive disease with limited and, very often, ineffective medical and surgical therapeutic options. The treatment of patients with advanced unresectable PDAC is restricted...
3.
Londin E, Loher P, Telonis A, Quann K, Clark P, Jing Y, et al.
Proc Natl Acad Sci U S A
. 2015 Feb;
112(10):E1106-15.
PMID: 25713380
Two decades after the discovery of the first animal microRNA (miRNA), the number of miRNAs in animal genomes remains a vexing question. Here, we report findings from analyzing 1,323 short...
4.
Showalter S, Charles S, Belin J, Cozzitorto J, Einstein P, Richards N, et al.
Expert Opin Drug Deliv
. 2010 Mar;
7(3):273-84.
PMID: 20201734
Recent preclinical data have demonstrated that pancreatic adenocarcinoma (PDA) cells with defects in the Fanconi anemia/BRCA2 pathway are hypersensitive to interstrand crosslinking agents. The challenge is to efficiently identify patients...
5.
Brody J, Costantino C, Potoczek M, Cozzitorto J, McCue P, Yeo C, et al.
Mod Pathol
. 2009 Mar;
22(5):651-9.
PMID: 19270646
Adenosquamous carcinoma of the pancreas is one of the most aggressive forms of pancreatic cancer. Molecular characterizations of this rare tumor subtype are sparse. Understanding the common molecular and pathologic...
6.
Witkiewicz A, Williams T, Cozzitorto J, Durkan B, Showalter S, Yeo C, et al.
J Am Coll Surg
. 2008 May;
206(5):849-54.
PMID: 18471709
Background: The mechanism by which pancreatic ductal adenocarcinoma (PDA) cells escape immune detection and survive in lymph nodes is poorly understood. One possible mechanism by which PDA cells can escape...
7.
Brody J, Witkiewicz A, Williams T, Kadkol S, Cozzitorto J, Durkan B, et al.
Mod Pathol
. 2007 Oct;
20(12):1238-44.
PMID: 17906614
Nuclear phosphoprotein 32 (pp32) inhibits K-ras induced transformation in experimental models. pp32 mRNA expression correlates with differentiation status in breast and prostate cancers. In this study, we evaluated pp32 protein...
8.
Hugot K, Riviere M, Moreilhon C, Dayem M, Cozzitorto J, Arbiol G, et al.
Plant Physiol
. 2004 Feb;
134(2):858-70.
PMID: 14764907
Besides the systemic acquired resistance (SAR) induced in response to microbial stimulation, host plants may also acquire resistance to pathogens in response to endogenous stimuli associated with their own development....